Innobic

Innobic serves as a holding and investment platform in pharmaceuticals, medical technology, and nutrition, with commercialization and manufacturing activities conducted through its subsidiaries and partners, such as Lotus Pharmaceutical and Adalvo. It focuses on increasing drug access and technology transfer in the ASEAN region and emerging markets, targeting major therapeutic areas including oncology and biosimilars. Innobic itself does not directly develop its own drug pipeline, but enables manufacturing, licensing, commercialization, and technology transfer through its key partnerships and significant stakes in other companies.